You are here

Tempo inhaler

MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile

Pharmabiz

Sun, 08/14/11 - 11:32 am

MAP Pharmaceuticals